Analysts say Eli Lilly may have a future blockbuster drug on its hands: An experimental pill designed to lower ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

Obesity is a major global health crisis, especially in the United States, but newer weight-loss drugs like Eli Lilly’s (LLY) Zepbound could offer a long-awaited solution — if they become more ...

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug ... Zepbound should be used in combination with a reduced-calorie diet and increased physical activity, the ...

The lawsuit was brought against the FDA after the agency declared an end to the shortage that allowed pharmacies to sell compound versions of the popular weight loss drugs, but Eli Lilly said it ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

But what investors are really eager to find out is if the company may have a GLP-1 weight loss pill in its portfolio in the near future. By April 2025, Eli Lilly expects it will have data to ...

On the other hand, Eli Lilly is working on the next generation of weight management treatments. The most advanced product candidates in this sector are Orforglipron (GLP-1 oral pill), and ...

The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity ...